The Foulkes Foundation Medal has been awarded biennially since 2007 to a (clinical) scientist who has shown outstanding achievements in research within ten years of being awarded their PhD. Applicants are put forward by Fellows of the Academy of Medical Sciences, which handles the administration of this prestigious award.
SIXTH FOULKES FOUNDATION MEDAL
Dr Cristina Lo Celso has been awarded the 2017 Foulkes Foundation Medal. Dr Lo Celso is a Reader in Stem Cell Biology at Imperial College London and uses stem cells to study how leukaemia develops and relapses. Dr Lo Celso’s prolific career has stretched across several disciplines and countries, taking her from Italy to England via the USA. By working internationally and setting up an interdisciplinary laboratory, she has set out a clear example of integrative and shared global science, both of which are key passions of hers. More recently she has made great advances in looking at the way in which leukaemia cells move around the body, and why the bodies’ bone-making cells disappear during the development of the disease. The aim of this research is to optimise bone marrow transplantation and treatments for the most common type of adult leukaemia.
FIFTH FOULKES FOUNDATION MEDAL
Dr Nitzan Rosenfeld was awarded the fifth Foulkes Foundation Medal in 2015. He is Senior Group Leader at Cancer Research U.K. Cambridge Institute, based at Addenbrooke’s Hospital. His research has centred on non-invasive diagnostic tools for cancer using circulating DNA. The Institute’s work has also resulted in a method for the sequencing of circulating cancer DNA that can identify cancer mutations during treatment. Nitzan is the founder and Chief Scientific Officer of a spin-out company using circulating DNA analysis to improve testing and treatment for oncologists.
Fourth Foulkes Foundation Medal
The winner of the 2013 Foulkes Foundation Medal is Dr Akhilesh Reddy FMedSci, a neuroscientist and Wellcome senior clinical research fellow at the Wellcome Trust – MRC Institute of Metabolic Science, University of Cambridge.
Dr Reddy’s research focuses on how disruption of circadian rhythms in the brain affects health and life expectancy, and specifically on the role of sleep dysfunction in patients with neurodegenerative disorders such as Parkinson’s disease.
Third Foulkes Foundation Medal
Professor Patrick Chinnery FMedSci has been awarded the 2011 Foulkes Foundation Medal. A Wellcome Trust Senior Clinical Fellow since 2003, Professor Chinnery continues to study the inheritance and expression of mitochondrial disorders both in the clinic and in the molecular laboratory, running several clinical trials in rare genetic diseases. Professor Chinnery was appointed Professor of Neurogenetics in 2004, studying mitochondrial mechanisms in late-onset multi-factorial diseases including stroke and Parkinson’s disease. He became an NIHR Senior Investigator in 2010 and was recently appointed Director of Newcastle University’s Institute of Genetic Medicine. He was elected a Fellow of the Academy of Medical Sciences in 2009.
SECOND FOULKES FOUNDATION MEDAL
The second Foulkes Foundation Medal was awarded in December 2009 at the Annual General Meeting of the Academy of Medical Sciences, who are administering this scheme jointly with the Foundation, to Professor Peter Rothwell, FMedSci, of the Department of Clinical Neurology at the University of Oxford. Prof. Rothwell’s work has revolutionised the treatment of transient ischaemic attacks, or ‘mini-strokes’, and minor stroke. His contribution to medical scientific knowledge during his relatively short research career has been remarkable and there can be few more inspirational demonstrations of the impacts of research on clinical practice. His recent findings on the link between variability in blood pressure and risk of stroke, and the effects of aspirin on risks of cancer and infection, promise to have a similar impact.
Prof. Rothwell is founding Director of the Stroke Prevention Research Unit at the University of Oxford, set up in 2000 and now employing over 30 staff, which is considered to be one of the most successful stroke research groups in the world.